Empiric Quinidine for Asymptomatic Brugada Syndrome

 

Purpose:
The purpose of this study is to determine if Quinidine therapy (not guided by the results of electrophysiologic studies) will reduce the long-term risk of arrhythmic events in asymptomatic Brugada Syndrome.

Official Title:
A Prospective Trial Of Empiric Quinidine Therapy For Asymptomatic Brugada Syndrome.
 
Who Can Participate:
Patients with type I Brugada electrocardiogram (either spontaneous or following a drug challenge with sodium channel blocker) who never experienced arrhythmia-related symptoms. Patients will receive Quinidine therapy at the discretion of the attending physician. 

The trial is registered at:
http://clinicaltrials.gov/ct2/show/NCT00789165?term=brugada&rank=2

More Information about the study: http://www.brugadasyndrome.info/

For questions, contact Lynn Johnson, Director of Family Support, at 1-801-272-3023 or Lynn@sads.org.